FDA Issues Warning Letters To Firms Marketing Products Containing 7-Hydroxymitragynine

July 15 (Reuters) - FDA:

• FDA ISSUES WARNING LETTERS TO FIRMS MARKETING PRODUCTS CONTAINING 7-HYDROXYMITRAGYNINE

• FDA: WARNING LETTERS LETTERS SPECIFICALLY FOCUS ON PRODUCTS CONTAINING 7-OH AS AN ADDED INGREDIENT OR ENHANCED LEVELS OF 7-OH

• FDA: ISSUED WARNING LETTERS TO SHAMAN BOTANICALS, MY SMOKE WHOLESALE, RELAX RELIEF REJUVENATE TRADING, LLC DBA RRR TRADING OR EDP KRATOM

• FDA: ISSUED WARNING LETTERS TO THANG BOTANICALS, ROYAL DIAMOND IMPORTS, HYDROXIE, LLC & 7TABZ RETAIL, LLC